Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jane van Warmerdam"'
Autor:
Elliott Vichinsky, Frans A. Kuypers, Diane Kepka-Lenhart, Lorenzo Machado, Jane Van Warmerdam, Sidney M. Morris, Claudia R. Morris
Publikováno v:
Journal of pediatric hematology/oncology. 25(8)
Purpose: Recent data suggest that hydroxyurea (HU) increases the production of nitric oxide (NO), a potent vasodilator. NO is normally metabolized from L-Arginine (Arg). However, in vitro and animal experiments suggest that HU is the NO donor itself.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb21d0e3db6f17c5341ee1dc92f34b6
https://pubmed.ncbi.nlm.nih.gov/12902916
https://pubmed.ncbi.nlm.nih.gov/12902916
Autor:
Ward Hagar, Elliott Vichinsky, Sidney M. Morris, Jane Van Warmerdam, Claudia R. Morris, Susan Claster, Diane Kepka-Lenhart, Frans A. Kuypers, Lorenzo Machado
Publikováno v:
American journal of respiratory and critical care medicine. 168(1)
Pulmonary hypertension is a life-threatening complication of sickle cell disease. L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis. This deficiency may play a ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb0cbfe933524b9204191f83be9c6e72
https://pubmed.ncbi.nlm.nih.gov/12826592
https://pubmed.ncbi.nlm.nih.gov/12826592
Autor:
Carolyn Hoppe, Katie Allen, Elliott Vichinsky, Keith Quirolo, Jane Van Warmerdam, Lori Styles
Publikováno v:
Pediatric Research. 45:147A-147A
The Safety and Efficacy of Hydroxyurea in 2 to 5 Year Old Children with Sickle Cell Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6be093f0076c38fa95eed8e3e23785aa
https://doi.org/10.1203/00006450-199904020-00876
https://doi.org/10.1203/00006450-199904020-00876
Autor:
Claudia R. Morris, Elliott P. Vichinsky, Jane van Warmerdam, Lorenzo Machado, Diane Kepka-Lenhart, Sidney M. Morris Jr., Frans A. Kuypers
Publikováno v:
Journal of Pediatric Hematology/Oncology; Aug2003, Vol. 25 Issue 8, p629-634, 6p